Edition:
United States

Celsion Corp (CLSN.PH)

CLSN.PH on Philadelphia Stock Exchange

1.85USD
21 Jul 2017
Change (% chg)

$-0.09 (-4.64%)
Prev Close
$1.94
Open
$1.85
Day's High
$1.85
Day's Low
$1.85
Volume
100
Avg. Vol
1,877
52-wk High
$19.32
52-wk Low
$1.84

Latest Key Developments (Source: Significant Developments)

Intracoastal Capital reports 8.3 pct passive stake in Celsion
Friday, 14 Jul 2017 04:37pm EDT 

July 14 (Reuters) - Celsion Corp :Intracoastal Capital Llc reports 8.3 percent passive stake in Celsion Corp as of July 6 - SEC filing.  Full Article

Celsion Corp agreed to sell about 2.435 million shares of common stock
Thursday, 6 Jul 2017 09:15am EDT 

July 6 (Reuters) - Celsion Corp ::Celsion Corporation announces $5 million registered direct offering.Celsion Corp - agreed to sell about 2.435 million shares of common stock, or pre-funded warrants , at price of $2.07 per common share or warrant share.  Full Article

Celsion announces $5.4 million registered direct offering
Monday, 19 Jun 2017 09:15am EDT 

June 19 (Reuters) - Celsion Corp :Celsion corporation announces $5.4 million registered direct offering.Celsion corporation announces $5.4 million registered direct offering.Celsion corp - entered agreements with several institutional investors to purchase an aggregate of approximately $5.4 million of shares of common stock.Celsion corp - agreed to sell about 2 million shares of common stock, pre-funded warrants at a price of $2.75 per common share or warrant share.Celsion - estimated net proceeds from sale of shares of stock or pre-funded warrants in registered direct offering are expected to be about $4.8 million.  Full Article

Celsion files to withdraw stock offering
Friday, 16 Jun 2017 07:53am EDT 

June 16 (Reuters) - Celsion Corp -:Files to withdraw stock offering - sec filing.  Full Article

Celsion Corp files to withdraw stock and warrants offering
Friday, 16 Jun 2017 07:53am EDT 

June 16 (Reuters) - Celsion Corp :Celsion Corp <<>> - Files to withdraw stock offering - SEC filing.Celsion - As per co's amended S-1 form on June 15, offering had been for 2.45 million shares of co's common stock and warrants to purchase 4.1 million shares of co's common stock.  Full Article

Celsion Corp announces stock consolidation
Friday, 26 May 2017 04:05pm EDT 

May 26 (Reuters) - Celsion Corp :Celsion Corp announces stock consolidation.Is effecting a 1 for 14 reverse stock split of its common stock.Reverse stock split of its common stock which will be effective for trading purposes as of commencement of trading on May 30, 2017.  Full Article

Celsion Corp reports Q1 loss share per $0.12
Friday, 12 May 2017 08:00am EDT 

May 12 (Reuters) - Celsion Corp -:Celsion Corporation reports first quarter 2017 financial results and provides business update.Q1 loss share per $0.12.Q1 earnings per share view $-0.09 -- Thomson Reuters I/B/E/S.Celsion Corp - research and development costs were relatively constant at $3.5 million and $3.4 million in first quarters of 2017 and 2016, respectively.Celsion Corp - plans to activate 5 additional clinical trial sites in vietnam by q2 of 2017 for optima study.Celsion Corp - company ended q1 of 2017 with $4.5 million of total cash and cash equivalents.  Full Article

Celsion Corp files for stock shelf of up to $15 mln
Tuesday, 25 Apr 2017 05:12pm EDT 

April 25 (Reuters) - Celsion Corp :Celsion Corp files for stock shelf of up to $15 million - SEC filing.  Full Article

Celsion Corp says selling stockholders may offer up to 5.1 mln shares of common stock - SEC Filing
Wednesday, 5 Apr 2017 05:39pm EDT 

Celsion Corp :Celsion Corp - Selling stockholders may offer up to 5.1 million shares of common stock, issuable upon exercise of outstanding warrants - SEC Filing.  Full Article

Celsion presents two posters on its GEN-1 IL-12 gene-mediated immunotherapy
Monday, 27 Feb 2017 08:30am EST 

Celsion Corp : Celsion presents two posters on its GEN-1 IL-12 gene-mediated immunotherapy at the ASCO-SITC clinical immuno-oncology symposium . Celsion Corp - in first twelve patients dosed in ovation study, GEN-1 plus standard chemotherapy produced impressive clinical results . Celsion Corp - Celsion expects to complete enrollment and treatment phase of ovation study early in Q2 .Celsion - expects to report final data from ovation study , including translational data for all patients, by end of Q2 of 2017.  Full Article

BRIEF-Celsion Corp says Anson Funds Management LP reported 9.6 pct passive stake in Co as of July 6 - SEC filing

* Anson Funds Management LP reports 9.6 percent passive stake in Celsion Corp as of July 6 - SEC filing Source text: (http://bit.ly/2uBZEHu) Further company coverage: